Results
Sun Pharma Q4 FY26 Net Profit INR 27.1 Billion
Sun Pharma reported Q4 FY26 sales of INR 145.6 billion, up 13.6% YoY, with a net profit of INR 27.1 billion.
The company provided FY27 revenue growth guidance of high single-digits and expects R&D spe